The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.
Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...
Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in ...
The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...
The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...
Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...
The National Reconstruction Fund Corporation (NRFC) has taken a $54 million stake in Australian medical device company Synchron, to support the production of minimally invasive Brain-Computer ...
In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...
With a total of 570 exhibits, the China Pavilion at the Country Exhibition of the ongoing 8th China International Import Expo ...
The National Reconstruction fund has joined Amazon founder Jeff Bezos and other Silicon Valley heavyweights in backing ...
Synchron announced today that it raised $200 million in a Series D financing round to support the commercialization of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback